Navigation Links
Controlling parasitic worms with genetic selection
Date:12/19/2013

Helminths are gastrointestinal parasitic worms that have become a major concern and source of economic loss for sheep producers around the world. A new article published today in the Canadian Journal of Animal Science reviews current research into a promising alternative to control the disease.

According to the paper, the sheep industry has become dependent on drugs to control these parasites. Over time these drugs are less effective as helminths become resistant to the drugs. Therefore, there is pressure on the industry to find alternate strategies. One such strategy is genetic selection. Certain breeds of sheep are more immune to helminths than the conventional breeds used in Canada, and a breeding program that aims to pass on this resistance trait could help to control the disease and ultimately limit production losses attributed to helminth infection.

A key advantage to applying genetic selection rather than chemicals to get rid of the worms is that it is permanent and it could help reduce the potential risk of chemical residues in products made for human consumption. This is key for the public as well as the sheep industry.

"With today's developments in genomic selection, breeding sheep for helminth resistance can be achieved efficiently, without adversely affecting other economically important traits," explained Niel Karrow, lead author of the paper, a researcher at the Centre for Genetic Improvement of Livestock at the University of Guelph.

"We believe that breeding for helminth resistance, when combined with good biosecurity and pasture management practises, will greatly help to control against production losses due to gastrointestinal parasites."


'/>"/>

Contact: Jenny Ryan
jenny.ryan@nrcresearchpress.com
Canadian Science Publishing (NRC Research Press)
Source:Eurekalert

Page: 1

Related biology news :

1. Oregon scientists offer new insights on controlling nanoparticle stability
2. Controlling the triggers of age-related inflammation could extend healthspan
3. Controlling genes with light
4. Cell-permeable peptide shows promise for controlling cardiovascular disease
5. White blood cells found to play key role in controlling red blood cell levels
6. New approaches for controlling pesticide exposure in children
7. Discovery of Africa moth species important for agriculture, controlling invasive plants
8. Could chloroplast breakthrough unlock key to controlling fruit ripening in crops?
9. New neural pathway controlling skeletal development discovered
10. Controlling gait of horses may be possible, says key study from Texas A&M
11. Controlling gene expression: How chromatin remodelers block a histone pass
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2014)... 4, 2014  Tute Genomics, a leader in cloud-based ... Series A1 funding led by UK-based Eurovestech. Peak Ventures ... the investment round. "We are at a ... next-generation sequencing and seeks new approaches for the diagnosis, ... , MD MBA, and CEO of Tute Genomics. "One ...
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... York College, and one of the most prolific inventors ... that are transmitted from Smartphones to third party agencies. ... and has one of the earliest known patents in ... usage in the military, child care, elder care and ...
(Date:11/18/2014)... , Nov. 17, 2014   ... and EMC collaborate to develop The Partners Data ... , The Partners Data Lake will allow researcher ... improve diagnostics, treatment and the lives of patients ... research and clinical activities across the Partners system, ...
Breaking Biology News(10 mins):Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 2Tute Genomics Raises $2.3 Million to Scale Up Cloud-Based Genome Analytics and Accelerate Personalized Medicine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... than a decade to understand how tiny molecules called ... that microRNA actually moves between cells to help them ... of cells that grow and develop. This discovery ... including medical gene therapy and bioengineering of crop plants. ...
... simplify lab-on-a-chip devices that could offer quicker, cheaper ... researchers have created microfluidic integrated circuits. Just ... electricity on computer chips without external controls, these ... their devices without instructions from outside systems. ...
... is available in <A HREF=",http://chinese.eurekalert.org/zh/pub_releases/2010-04/sfeb-phr042210.php,">Chinese . ... with extraordinarily complex fluctuations across a wide range of ... both clinical and dynamical significance it may provide ... of the heart,s pacemaking system. In work published ...
Cached Biology News:Production of biofuels could benefit by controlling the types of cells that develop in plants 2Microfluidic integrated circuit could help enable home diagnostic tests 2Microfluidic integrated circuit could help enable home diagnostic tests 3Periodic heart rate decelerations in premature infants 2Periodic heart rate decelerations in premature infants 3
(Date:12/19/2014)... Diego, CA (PRWEB) December 18, 2014 ... a limited time special on Sartorius Biohit products ... Free on mLINE pipettes, Picus Electronic Pipette Trade-in Program, ... by Health and Safety officers around the world. They ... manual pipetting. Other features include:, ,     Full ...
(Date:12/19/2014)... Egenix, Inc. is pleased to announce that ... Board, to succeed Donald Fresne ; Mr. Fresne has ... a member of the Board.  In recognition of the many ... over almost twenty years, the Board designated Mr. Fresne as ... established a Search Committee to find a suitable replacement with ...
(Date:12/19/2014)... , Dec. 18, 2014 Relmada Therapeutics, ... for the treatment of chronic pain, announced the results ... "This was a transformational year in Relmada,s ... future for our company," said Sergio Traversa , ... we have executed on key financial, human resource and ...
(Date:12/17/2014)... Based on the revenues gained ... market is dominated by four major players contributing ... These players include GE Healthcare (U.K.), Siemens AG ... , Full Report Copy at http://www.marketsandmarkets.com/Market-Reports/surgical-imaging-market-210534462.html ... be attributed to its strong product portfolio, which ...
Breaking Biology Technology:Major Pipette Distributor Pipette.com Announces Sartorius Year End Specials 2Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 2Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 3Global Refurbished Surgical Imaging Market by Product & Application is Estimated to Reach $1.25 Billion by 2019 - New Research Report by MarketsandMarkets 4
... of Commercial Operations - ... - ... Calif., Aug. 28 PDL BioPharma, Inc.,(PDL) (Nasdaq: PDLI ) ... discovery and development of novel antibodies in,oncology and select immunological diseases, ...
... Society,(ACS) presented the research teams involved in the development ... this week,at the 234th ACS National Meeting in Boston. ... first of its kind in the world -- now,commercially ... Lyle Bio,Products joint venture. The Heroes of Chemistry ...
... label,design and printing software solutions to healthcare providers, blood banks ... ... Niceware(R) International, LLC is,excited to announce that ICCBBA, Inc. granted licensing ... solutions that support ISBT 128-compliant data structures and bar,codes. The ...
Cached Biology Technology:PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 2PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 3PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 4PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 5DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM) 2DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM) 3DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM) 4Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software 2
Prostaglandin-E2 receptor EP2/EP3 Market Segment: GPCRs...
... - Red, 20X Immunogen ... at 20X concentration for use in ... Quality Assurance ... fluorescence polarization assays. ...
Goat polyclonal to SPFH2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: EDEPLETATKEN, corresponding to C terminal amino acids 328-339 of Human SPFH2 Entrez Gene ID: 11...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Biology Products: